In the specialized field of biochemical research, the exploration of targeted delivery mechanisms remains HN-1 is a 12-mer peptide(C57H96N18O18) demonstrating selective binding activity against head and neck squamous cell carcinoma (HNSCC) cell lines.Read more a focal point for scientists worldwide. Among the various molecules studied for their high specificity, the HN-1 peptide stands out as an intriguing subject of investigation. As an enthusiast who follows advancements in peptide science, I have spent significant time review As HN-1 peptide lacks the recognition motif (RGD) of integrin,HN-1 may interact with an "integrinlike" molecule. HN-1 is internalized by attached cells but not Read more ing the literature surrounding this specific 12-mer molecule.
What is the HN-1 Peptide?
At its core, the HN-1 peptide is defined as a 12-amino acid peptide with the sequence Our initial studies were based on a compound known asHN-1, TSPLNIHNGQKL, which has previously been shown to be internalized and is cytotoxic to cancer cells Read more TSPLNIHNGQKL. Researchers often highlight that it is a tumor-specifically internalizing peptide, a property that makes it a subject of intense academic scrutiny. Because it is a 12-mer peptide, it possesses a significantly lower molecular mass—approximately 1% of the mass of typical antibodies— by B O'Gorman·2025·Cited by 2—In humans, ATX-101 has a short plasma half-life (intravenous, plasma T1/2 < 0.5 Hrs), in line with manypeptidetherapeutics, but is capable of penetrating Read more which researchers suggest may facilitate better penetration and distribution in experimental models.
One of the most fascinating aspects of this molecule is its mechanism of action. Scientific data indicates that the targeting of HN-1 peptide is highly selective. Unlike other common delivery vectors, it appears to function independently of the typical integrin recognition motif (RGD). Instead, evidence suggests that HN-1 may interact with an "integrin-like" molecule or other surface receptors to achieve its internalizing capabilities.
Key Research Findings and Mechanisms
The scientific community has dedicated considerable effort to identifying how this molecule functions at the cellular level. A major breakthrough in recent years has been the identification of DDR1 as the HN-1 peptide's putative receptor. Discoidin domain receptor 1 (DDR1) is frequently overexpressed in various cellular models, and the discovery of this interaction has helped explain why the peptide shows such high affinity for specific cell types.
When discussing the application of this molecule, it is essentia Identification of HN-1-Peptide Target in Head and Neck - PMC l to distinguish between different variants. For instance, while some literature references Hainanenin-1 (HN-1) as a host defense peptide derived from frog skin, the primary focus in the context of targeted delivery remains the synthetic 12-mer sequence. Furthermore, researchers have explored the development of a bifunctional HN-1-PKCepsilon inhibitory peptide, w by Z Liu·2020·Cited by 17—The present study aimed to examine the diagnostic and prognostic value ofHN1in terms of overall survival (OS) and recurrence-free survival (RFS) in liver Read more hich combines the homing capabilities of the peptide with other functional motifs to achieve more complex biochemical objectives.
Why HN-1 Remains a Subject of High Interest
The reason HN-1 peptide targets human head and neck squamous cell carcinoma (HNSCC) and other related cell lines so effectively is due to its unique structural properties. As a 12-amino acid peptide, it is small enough to navigate complex biological environments while maintaining the structural integrity required to bind to its target.
For those of us observing these developments, it is clear that the HN-1 molecule represents a significant lead structure. Similar to how HBP-1 represents a promising lead structure for diagnostic procedures, the established affinity of the HN-1 sequence provides a reliable foundation for those looking to understand how molecular "homing" works.
Observations from the Field
In reviewing the available data, it is evident that the HN-1 molecule is one of the few agents whose cel Tumor specifically internalizing peptide 'HN-1' l affinity has been successfully reproduced across multiple independent laboratories. This consistency is a hallmark of high-quality research. Whether it is being used to study receptor-ligand interactions or as a carrier for various payloads, the HN-1 sequence continues to demonstrate why it by EM Nothelfer·2009·Cited by 63—HBP-1 represents a promising lead structurefor the development of targeted therapies or diagnostic procedures in patients with HNSCC. MeSH Read more is a staple in modern biochemical literature.
While the primary focus of this research remains purely academic and discovery-based, the precision with which this 12-mer peptide operates is a testament to the power of peptide engineering. By continuing to study the targeting of HN-1 peptide, scientists are paving the way for a deeper understanding of how we might one day design even more precise tools for molecular identification and interaction.